Home
>
US Stocks
>
Forte Biosciences Inc
Forte Biosciences Inc
FBRX

Forte Biosciences Inc (FBRX)

$2.6590.3%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
2.79
Today Low/High
2.65 / 2.79
52 Week Low/High
$21.09 / $53.99
P/E ratio
-5.9433
Market Cap
$360.9M

Company Details

Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric (3 years of age and older) patients with atopic dermatitis. There is a significant unmet need for safe and effective therapies particularly for pediatric atopic dermatitis patients. In September 2020, Forte initiated a multi-center, placebo controlled clinical trial of FB-401 which is expected to enroll pediatric, adolescent and adult AD subjects aged 2 years of age and older.
Organisation
Forte Biosciences Inc
Headquaters
Torrance, California, US
Employees
9
Industry
Health Technology
CEO
Martin Duvall

Discover more

Frequently Asked Questions

What is Forte Biosciences Inc (FBRX) share price today?

Can Indians buy Forte Biosciences Inc (FBRX) shares?

How can I buy Forte Biosciences Inc (FBRX) shares from India?

Can Fractional shares of Forte Biosciences Inc (FBRX) be purchased?

What are the documents required to start investing in Forte Biosciences Inc (FBRX) stocks?

We are a SEBI registered investement advisor